Archynetys Live news trend intelligence
↑ Rising Business

FDA announces nationwide recall of epinephrine injections after reports of cracked vials

Three lots of a key allergy injection are pulled nationwide after cracked vials raise sterility concerns.

8sources
8articles
6velocity
+102%since first seen
3h agofirst detected

Evidence dossier

Intelligence passport

55/100 Publishable
8distinct sources shown
4velocity measurements
1language editions checked
Unsupported statements were removed before publicationbrief evidence status

Measured timeline

  1. Detected The first matching coverage entered the Archynetys cluster.
  2. Evidence threshold reached The story had enough independent coverage for an explanatory brief.
  3. Latest coverage observed Most recent article currently attached to this story cluster.
  4. Peak measured velocity The recorded velocity reached 6.

Source diversity sample: The Lufkin Daily News · WWLP · Fierce Pharma · Morningstar · The Sun Times News · NTD News · USA Today · WESH.

How this dossier is built: methodology · AI policy · corrections.

Coverage (8)

What happened

Three lots of American Regent’s epinephrine injection, USP 30 mg/30 mL (1 mg/mL), are being withdrawn from the U.S. market in a nationwide recall. The FDA issued the alert after receiving reports of cracked vials, prompting immediate action to protect patients who rely on the life‑saving medication for severe allergic reactions.

The recall applies to all distribution channels across the country. Morningstar reported that the voluntary recall cites particulate matter and uncertainty about sterility as the technical reasons for the pull‑back.

USA Today listed the affected product specifications, and WESH noted the FDA’s official announcement, underscoring the breadth of the response across medical and news outlets.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (56% supported) Updated 3h ago.

Questions people are asking

Which products are included in the recall?

The recall covers three lots of American Regent’s epinephrine injection, USP 30 mg/30 mL (1 mg/mL).

What prompted the FDA to act?

Reports of cracked vials and concerns about particulate matter and sterility assurance led the FDA to announce the nationwide recall.

What should patients do if they have the medication?

Patients should check the lot numbers of their injection and contact their healthcare provider for guidance.

The coverage curve

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Topics

American Regent FDA epinephrine recall allergy medication nationwide recall

Related trends

Open prediction lab

Can you beat the machine?

Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.

Make a prediction →